| Electronic cigarette use and respiratory symptoms in adolescents R McConnell, JL Barrington-Trimis, K Wang, R Urman, H Hong, J Unger, ... American journal of respiratory and critical care medicine 195 (8), 1043-1049, 2017 | 433 | 2017 |
| Psychosocial factors associated with adolescent electronic cigarette and cigarette use JL Barrington-Trimis, K Berhane, JB Unger, TB Cruz, J Huh, AM Leventhal, ... Pediatrics 136 (2), 308-317, 2015 | 311 | 2015 |
| The e-cigarette social environment, e-cigarette use, and susceptibility to cigarette smoking JL Barrington-Trimis, K Berhane, JB Unger, TB Cruz, R Urman, CP Chou, ... Journal of Adolescent Health 59 (1), 75-80, 2016 | 139 | 2016 |
| Patterns of alternative tobacco product use: emergence of hookah and e-cigarettes as preferred products amongst youth TD Gilreath, A Leventhal, JL Barrington-Trimis, JB Unger, TB Cruz, ... Journal of Adolescent Health 58 (2), 181-185, 2016 | 135 | 2016 |
| Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup … DJ Kuter, A Newland, BH Chong, F Rodeghiero, MT Romero, I Pabinger, ... British Journal of Haematology 185 (3), 503-513, 2019 | 79 | 2019 |
| Perceived stress and poly-tobacco product use across adolescence: Patterns of association and gender differences AM Leventhal, R Urman, JL Barrington-Trimis, NI Goldenson, K Gallegos, ... Journal of psychiatric research 94, 172-179, 2017 | 50 | 2017 |
| Romiplostim use in pregnant women with immune thrombocytopenia JB Bussel, N Cooper, T Lawrence, M Michel, E Vander Haar, K Wang, ... American Journal of Hematology 98 (1), 31-40, 2023 | 14 | 2023 |
| Safety and efficacy of self‐administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials DJ Kuter, DM Arnold, F Rodeghiero, A Janssens, D Selleslag, R Bird, ... American Journal of Hematology 95 (6), 643-651, 2020 | 14 | 2020 |
| A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia J Grainger, J Bussel, M Tarantino, N Cooper, D Beam, J Despotovic, ... Blood Advances 7 (3), 396-405, 2023 | 8 | 2023 |
| Updated results from the single-arm, open-label, long-term efficacy and safety study of subcutaneous (SC) romiplostim in children with immune thrombocytopenia (ITP) J Grainger, JB Bussel, MD Tarantino, N Cooper, D Beam, JM Despotovic, ... Blood 134, 1095, 2019 | 6 | 2019 |
| Immunomodulatory second-line therapies for immune thrombocytopenia MP Lambert Hämostaseologie 39 (03), 266-271, 2019 | 6 | 2019 |
| Predictors of remission in adults with immune thrombocytopenia treated with romiplostim A Newland, JB Bussel, R Bird, DM Arnold, CM Kessler, J Mayer, ... Blood 132, 735, 2018 | 6 | 2018 |
| Comparison of the effects of the thrombopoietin (TPO) receptor agonist romiplostim in patients with immune thrombocytopenia (ITP) for≤ 1 Year vs.> 1 year DJ Kuter, A Newland, BH Chong, F Rodeghiero, MT Romero, I Pabinger, ... Blood 130, 1055, 2017 | 3 | 2017 |
| Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry C Bowers, DT Mytych, T Lawrence, K Wang, TE Barger, M Eisen, ... Blood Advances 5 (23), 4969-4979, 2021 | 2 | 2021 |
| Surveillance program of romiplostim use connected to pregnancy JB Bussel, N Cooper, T Lawrence, M Michel, E Vander Haar, K Wang, ... Blood 138, 585, 2021 | 2 | 2021 |
| Investigating the Potential Impact of Dosing Tolerance to Facilitate Use of Nplate Self-Administration in Adult Patients with ITP FS Castillo, HA Saad, K Wang, A Zhang, V Chow, S Doshi Blood 138, 4231, 2021 | | 2021 |
| UPDATED RESULTS FROM THE SINGLE ARM, OPEN LABEL, LONG TERM EFFICACY/SAFETY OF SC ROMI IN ITP IN PEDS C Bowers, J Grainger, J Bussel, M Tarantino, N Cooper, D Beam, ... PEDIATRIC BLOOD & CANCER 67, S18-S19, 2020 | | 2020 |
